| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 10.882 | 96.766 | 82.828 | 97.876 |
| Total Income - EUR | - | - | - | - | - | - | 10.882 | 97.214 | 84.536 | 98.804 |
| Total Expenses - EUR | - | - | - | - | - | - | 2.305 | 28.172 | 18.829 | 98.118 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 8.578 | 69.042 | 65.708 | 686 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 8.258 | 66.191 | 54.372 | -5.097 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Anafran S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 1.939 | 2.225 | 30.180 |
| Current Assets | - | - | - | - | - | - | 9.196 | 65.853 | 147.501 | 90.278 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 2.857 | 53.680 | 66.455 | 37.020 |
| Cash | - | - | - | - | - | - | 6.339 | 12.173 | 81.046 | 53.258 |
| Shareholders Funds | - | - | - | - | - | - | 8.298 | 66.240 | 120.411 | -5.049 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 898 | 1.552 | 29.315 | 125.548 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Anafran S.r.l.